Recent Finacing
Recent Raise
Aprecia Pharmaceuticals develops, manufactures, and markets 3D-printed fast-melt oral drug formulations (ZipDose), including FDA-approved SPRITAM for epilepsy, and scalable high-dose and low-dose delivery formats.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors